Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Macaulay

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2022
Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain LymphomasJurik A Mutter, Stefan K Alig, Mohammad S Esfahani, et al.
Nature Biotechnology|July 23, 2021
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNADavid M Kurtz, Joanne Soo, Lyron Co Ting Keh, et al.
Nature Biotechnology|April 1, 2022
Inferring gene expression from cell-free DNA fragmentation profilesMohammad Shahrokh Esfahani, Emily G Hamilton, Mahya Mehrmohamadi, et al.
Cancer Cell|December 30, 2022
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasBrian J Sworder, David M Kurtz, Stefan K Alig, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2022
Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain LymphomasJurik A Mutter, Stefan K Alig, Mohammad S Esfahani, et al.
Nature Biotechnology|July 23, 2021
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNADavid M Kurtz, Joanne Soo, Lyron Co Ting Keh, et al.
Nature Biotechnology|April 1, 2022
Inferring gene expression from cell-free DNA fragmentation profilesMohammad Shahrokh Esfahani, Emily G Hamilton, Mahya Mehrmohamadi, et al.
Cancer Cell|December 30, 2022
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasBrian J Sworder, David M Kurtz, Stefan K Alig, et al.
Pageof 3